Drug Discovery of DKK1 Inhibitors
Dickkopf-1 (DKK1) is a well-characterized Wnt inhibitor and component of the Wnt/β-catenin signaling pathway, whose dysregulation is associated with multiple abnormal pathologies including osteoporosis, Alzheimer's disease, diabetes, and various cancers. The Wnt signaling pathway has fundamenta...
Saved in:
Main Authors: | Hewen Jiang (Author), Zongkang Zhang (Author), Yuanyuan Yu (Author), Hang Yin Chu (Author), Sifan Yu (Author), Shanshan Yao (Author), Ge Zhang (Author), Bao-Ting Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug discovery of sclerostin inhibitors
by: Sifan Yu, et al.
Published: (2022) -
A bimolecular modification strategy for developing long-lasting bone anabolic aptamer
by: Huarui Zhang, et al.
Published: (2023) -
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential
by: Amu Gubu, et al.
Published: (2024) -
Advances in the discovery of exosome inhibitors in cancer
by: Huarui Zhang, et al.
Published: (2020) -
Preparation and evaluation of nattokinase-loaded self-double-emulsifying drug delivery system
by: Xiaona Wang, et al.
Published: (2015)